Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

The First Affiliated Hospital of Soochow University · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
acute-myeloid-leukemia
acute myeloid leukemia (aml), flt3-itd mutation, allogeneic hematopoietic cell transplantation (hct), maintenance therapy, gilteritinib, sorafenib, acute myeloid leukemia, allogeneic hematopoietic cell transplantatio, sorafeni, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1044966
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.